130 related articles for article (PubMed ID: 8178805)
1. Myelomonocytic crisis with t(5;17) and a p53 mutation in a patient with chronic myelogenous leukemia.
Nakagawa H; Fujii H; Nakai H; Inazawa J; Misawa S
Am J Hematol; 1994 Apr; 45(4):335-40. PubMed ID: 8178805
[TBL] [Abstract][Full Text] [Related]
2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
[TBL] [Abstract][Full Text] [Related]
4. p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis.
Stuppia L; Calabrese G; Peila R; Guanciali-Franchi P; Morizio E; Spadano A; Palka G
Cancer Genet Cytogenet; 1997 Oct; 98(1):28-35. PubMed ID: 9309115
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
[TBL] [Abstract][Full Text] [Related]
6. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
7. Double P53 point mutation in extramedullary blast crisis of chronic myelogenous leukemia.
Marasca R; Longo G; Luppi M; Barozzi P; Torelli G
Leuk Lymphoma; 1994 Dec; 16(1-2):171-5. PubMed ID: 7696924
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
9. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
Kokate P; Dalvi R; Mandava S
J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
[TBL] [Abstract][Full Text] [Related]
10. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
Becher R; Kloke O
Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro.
Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA
Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia.
Nakai H; Misawa S; Taniwaki M; Horiike S; Takashima T; Seriu T; Nakagawa H; Fujii H; Shimazaki C; Maruo N
Br J Haematol; 1994 Jun; 87(2):425-7. PubMed ID: 7947294
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis.
Nucifora G; Birn DJ; Espinosa R; Erickson P; LeBeau MM; Roulston D; McKeithan TW; Drabkin H; Rowley JD
Blood; 1993 May; 81(10):2728-34. PubMed ID: 8490181
[TBL] [Abstract][Full Text] [Related]
14. Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis.
Chen JC; Liu SM; Fei HB; Gong WL
J Tongji Med Univ; 1994; 14(4):204-8. PubMed ID: 7760428
[TBL] [Abstract][Full Text] [Related]
15. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
16. P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis.
Marasca R; Luppi M; Barozzi P; Ferrari MG; Morselli M; Torelli G
Leuk Lymphoma; 1996 Dec; 24(1-2):175-82. PubMed ID: 9049974
[TBL] [Abstract][Full Text] [Related]
17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17.
Rege-Cambrin G; Gaidano G; Serra A; Scaravaglio P; Guglielmelli T; Guerrasio A; Giovinazzo B; Saglio G
Leukemia; 1994 Apr; 8 Suppl 1():S23-6. PubMed ID: 8152298
[TBL] [Abstract][Full Text] [Related]
19. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.
Rovira A; Urbano-Ispizua A; Cervantes F; Rozman M; Vives-Corrons JL; Montserrat E; Rozman C
Ann Hematol; 1995 Mar; 70(3):129-33. PubMed ID: 7718641
[TBL] [Abstract][Full Text] [Related]
20. [Chromosome aberrations in chronic myeloid leukemia].
Haus O
Acta Haematol Pol; 1992; 23(2 Suppl 1):5-12. PubMed ID: 1488873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
